Louisiana State Employees Retirement System Purchases New Shares in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Louisiana State Employees Retirement System acquired a new position in Prestige Consumer Healthcare Inc. (NYSE:PBH) during the fourth quarter, HoldingsChannel reports. The fund acquired 24,800 shares of the company’s stock, valued at approximately $1,518,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Provence Wealth Management Group acquired a new stake in shares of Prestige Consumer Healthcare in the third quarter valued at approximately $26,000. Pacer Advisors Inc. increased its stake in shares of Prestige Consumer Healthcare by 85.7% in the 4th quarter. Pacer Advisors Inc. now owns 442 shares of the company’s stock valued at $27,000 after buying an additional 204 shares during the period. Altshuler Shaham Ltd bought a new stake in shares of Prestige Consumer Healthcare during the fourth quarter worth $27,000. ORG Partners LLC acquired a new position in shares of Prestige Consumer Healthcare during the fourth quarter valued at $36,000. Finally, Natixis bought a new position in Prestige Consumer Healthcare in the fourth quarter valued at about $36,000. Institutional investors and hedge funds own 99.95% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently weighed in on PBH. TheStreet upgraded shares of Prestige Consumer Healthcare from a “c+” rating to a “b-” rating in a research report on Monday, February 12th. StockNews.com raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, February 10th. One investment analyst has rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $110.00.

Insider Transactions at Prestige Consumer Healthcare

In related news, SVP Mary Beth Fritz sold 5,336 shares of Prestige Consumer Healthcare stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $69.00, for a total transaction of $368,184.00. Following the completion of the sale, the senior vice president now owns 15,934 shares of the company’s stock, valued at approximately $1,099,446. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.60% of the company’s stock.

Prestige Consumer Healthcare Trading Up 1.9 %

Shares of NYSE:PBH opened at $69.67 on Friday. The firm has a market cap of $3.46 billion, a price-to-earnings ratio of -42.48, a PEG ratio of 1.85 and a beta of 0.52. The company has a quick ratio of 1.92, a current ratio of 3.09 and a debt-to-equity ratio of 0.75. Prestige Consumer Healthcare Inc. has a 12 month low of $55.96 and a 12 month high of $75.31. The company’s fifty day simple moving average is $70.70 and its 200 day simple moving average is $63.81.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, February 8th. The company reported $1.06 EPS for the quarter, beating analysts’ consensus estimates of $1.04 by $0.02. The company had revenue of $282.74 million for the quarter, compared to analyst estimates of $280.25 million. Prestige Consumer Healthcare had a positive return on equity of 14.09% and a negative net margin of 7.11%. The company’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same period in the previous year, the company posted $1.04 earnings per share. As a group, research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.33 EPS for the current fiscal year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.